Inspire Medical Systems, Inc.

NYSE INSP

Inspire Medical Systems, Inc. Receivables for the quarter ending September 30, 2024: USD 89.74 M

Inspire Medical Systems, Inc. Receivables is USD 89.74 M for the quarter ending September 30, 2024, a 25.58% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Inspire Medical Systems, Inc. Receivables for the quarter ending September 30, 2023 was USD 71.46 M, a 47.35% change year over year.
Inspire Medical Systems, Inc. Receivables for the quarter ending September 30, 2022 was USD 48.50 M, a 81.81% change year over year.
Inspire Medical Systems, Inc. Receivables for the quarter ending September 30, 2021 was USD 26.68 M, a 26.42% change year over year.
Inspire Medical Systems, Inc. Receivables for the quarter ending September 30, 2020 was USD 21.10 M, a 92.09% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

NYSE: INSP

Inspire Medical Systems, Inc.

CEO	Mr. Timothy P. Herbert
IPO Date	May 3, 2018
Location	United States
Headquarters	5500 Wayzata Boulevard
Employees	1,011
Sector	Technology
Industries 3D Printing Biotechnology Clinical Trials Dental Care Medical Instruments Pollution Treatment Robotics Telehealth

Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Key trends

Past 5 years